Wells Fargo Upgrades Myriad Genetics (MYGN) to Outperform
Tweet
Share
E-mailGet Alerts MYGN Hot Sheet
Price: $17.98 -3.49%
Rating Summary:
8 Buy, 15 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 1
Rating Summary:
8 Buy, 15 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 1
Join SI Premium – FREE
Wells Fargo upgraded Myriad Genetics (NASDAQ: MYGN) from Market Perform to Outperform.
For an analyst ratings summary and ratings history on Myriad Genetics click here. For more ratings news on Myriad Genetics click here.
Shares of Myriad Genetics closed at $31.41 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo Upgrades Neurocrine Bio. (NBIX) to Overweight 'as the Company is Knocking on the Doors of the Large-Cap Club'
- JPMorgan Upgrades STO Express Co Ltd (002468:CH) to Neutral
- HSBC Upgrades UPS (UPS) to Buy, 'Back to earnings growth'
Create E-mail Alert Related Categories
UpgradesRelated Entities
Wells FargoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
